Rising demand for gene and cell therapies, expanding mRNA vaccine pipelines, and increasing investments in GMP-compliant manufacturing facilities are driving growth in the viral vectors and plasmid ...
Today, after receiving a gene therapy developed at the University of California San Diego, Natalie is thriving at 34 years ...
The gene therapies for cardiomyopathies market is poised for strong growth as advancements in genomic medicine accelerate the ...
Discover top biotech companies for 2026, featuring emerging stars and leaders set for major clinical and regulatory ...
The treatment uses a modified, harmless virus to deliver healthy genes to a patient’s cells to treat genetic diseases. Read ...
Hemophilia B, a genetic bleeding disorder caused by deficient factor IX activity, has traditionally required lifelong ...
Detailed price information for Abeona Therapeutics (ABEO-Q) from The Globe and Mail including charting and trades.
Mordor Intelligence has published a new report on gene prediction tools market offering a comprehensive analysis of trends, growth drivers, and future projections.
Ajinomoto launches CELLiST AAV Production Supplement 1, boosting gene therapy viral vector productivity by 1.3-2x.
Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced activation of The University of Texas Medical Branch (UTMB) in ...
OverviewThe global viral vector manufacturing market is projected to expand at a robust CAGR of approximately 20% over the forecast period, supported by multiple transformative forces reshaping the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback